These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 23412589)

  • 1. Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement.
    Goulart H; Sastow D; Moshier E; Martin L; Mascarenhas J; Tremblay D
    Leuk Res; 2024 Feb; 137():107452. PubMed ID: 38335816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement.
    Sastow D; Tatarian J; Riazat-Kesh YJRA; Farina K; Becker M; Feld J; Kremyanskaya M; Mascarenhas J; Byrd K; Male HJ; Lin TL; Tremblay D
    Leuk Lymphoma; 2023 Dec; 64(12):2002-2007. PubMed ID: 37590099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012 to 2022.
    Sastow D; Van Hyfte G; Feld J; Kremyanskaya M; Mascarenhas J; Tremblay D
    Acta Haematol; 2024; 147(3):292-299. PubMed ID: 37751713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailored central nervous system-directed treatment strategy for isolated CNS recurrence of adult acute myeloid leukemia.
    Zheng C; Liu X; Zhu W; Cai X; Wu J; Sun Z
    Hematology; 2014 Jun; 19(4):208-12. PubMed ID: 24074528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and risk factors for central nervous system relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
    Chen Q; Zhu XL; Zhao X; Liu X; Fu HX; Zhang YY; Chen YH; Mo XD; Han W; Chen H; Yan CH; Wang Y; Chang YJ; Xu LP; Huang XJ; Zhang XH
    Ann Hematol; 2021 Feb; 100(2):505-516. PubMed ID: 33389025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia.
    Alakel N; Stölzel F; Mohr B; Kramer M; Oelschlägel U; Röllig C; Bornhäuser M; Ehninger G; Schaich M
    Cancer Manag Res; 2017; 9():97-102. PubMed ID: 28435324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late relapse following autologous bone marrow transplantation for acute myelogenous leukemia: case report and review of the literature.
    Dann EJ; Gillis S; Rowe JM
    Leukemia; 1995 Jun; 9(6):1072-4. PubMed ID: 7596172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal donor lymphocyte infusion for isolated leukemia relapse in the central nervous system following allogeneic stem cell transplantation: a case report and literature review.
    Yanagisawa R; Nakazawa Y; Sakashita K; Saito S; Tanaka M; Shiohara M; Shimodaira S; Koike K
    Int J Hematol; 2016 Jan; 103(1):107-11. PubMed ID: 26586462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very late isolated CNS relapse of acute myeloid leukemia.
    Molina B; Lassaletta A; Gonzalez-Vicent M; Andión M; Diaz MA; Madero L
    J Pediatr Hematol Oncol; 2013 Mar; 35(2):e57-9. PubMed ID: 23412589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.
    Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
    J Clin Oncol; 2005 Dec; 23(36):9172-8. PubMed ID: 16361619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with central nervous system involvement.
    Aoki J; Ishiyama K; Taniguchi S; Fukuda T; Ohashi K; Ogawa H; Kanamori H; Eto T; Iwato K; Sakamaki H; Morishima Y; Nagamura T; Atsuta Y; Takami A
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2029-33. PubMed ID: 25196856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated extramedullary relapse presenting as autologous lymphocyte response.
    Imataki O; Ohnishi H; Kitanaka A; Kubota Y; Tanaka T; Ishida T
    Am J Hematol; 2008 Jun; 83(6):512-4. PubMed ID: 18306363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
    Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J
    Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.